Antidiabetic Effect of Olive Pomace Oil
Launched by INSTITUTO DE CIENCIA Y TECNOLOGÍA DE ALIMENTOS Y NUTRICIÓN · Dec 6, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether adding olive pomace oil to the diets of people with type 2 diabetes or those at risk of developing diabetes (like prediabetic individuals) can help manage their blood sugar levels. Researchers want to find out if this oil can prevent spikes in blood sugar after meals, lower fasting blood sugar levels, and improve overall blood sugar control and other health issues related to diabetes, such as high cholesterol or inflammation. To do this, they will compare the effects of olive pomace oil with another type of oil called high-oleic acid sunflower oil.
To participate in the study, individuals should have a fasting blood sugar level between 100-126 mg/dL or have a higher level if they are already diagnosed with diabetes. Participants will go through a series of dietary changes over about five months, including eating specific oils on bread and undergoing regular check-ups. They will also keep track of their physical activity and any medications they take. This trial is open to anyone aged 18 to 70, and it’s important to note that people with certain health conditions, dietary restrictions, or who are pregnant cannot participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Fasting blood glucose between 100-126 mg/dL and/or
- • Glycated haemoglobin (HbA1c) between 5.7-6.4% and/or
- • Diabetic persons with Fasting blood glucose \>126 mg/dL and/or
- • Diabetic persons with Glycated haemoglobin (HbA1c) \> 6.4%
- Exclusion Criteria:
- • Kidney or liver diseases
- • Gastrointestinal diseases (irritable bowel syndrome, Crohn disease, chronic bowel inflammation)
- • Food allergies/intolerances
- • Vegetarians/vegans
- • Smoking
- • Pregnant or lactating women
- • On prescription drugs other than for hypertension/thyroid/dyslipidemia/glucose control, or changes in dosage in the last 3 months
- • Consumption of vitamins, dietary supplements or nutraceuticals
About Instituto De Ciencia Y Tecnología De Alimentos Y Nutrición
The Instituto de Ciencia y Tecnología de Alimentos y Nutrición (ICTAN) is a leading research institution dedicated to advancing the fields of food science and nutrition. With a strong emphasis on innovative research, ICTAN aims to enhance public health through the development of safe, nutritious, and sustainable food products. The institute collaborates with academic, governmental, and industry partners to conduct clinical trials and studies that address critical nutritional challenges, promote healthy eating practices, and contribute to the scientific understanding of food-related health issues. Through its rigorous research methodologies and commitment to excellence, ICTAN plays a vital role in shaping dietary guidelines and influencing food policy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Patients applied
Trial Officials
Laura Bravo, Professor
Principal Investigator
ICTAN-CSIC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported